Context Therapeutics Inc (CNTX) earnings · next report Nov 4, 2026

EPS consensus

−$0.09

Range −$0.16 – −$0.078 analystsYear ago −$0.10

Revenue consensus

$0

Range $0 – $08 analysts

Date and consensus: EODHD earnings calendar and estimates, refreshed every 6 hours. “Confirmed” means the provider lists the report session, which it sets once the company announces; “Estimated” is the provider’s expected date.

Options price in (Nov 4)

—

No options snapshot for this report yet (taken daily in the 7 days before a report, for stocks with listed options).

Average move after earnings

±15.3%

Absolute close-to-close move, 2 reports

Options-implied move: the at-the-money straddle (call + put) on the first expiry after the report, divided by the stock’s close, from EODHD end-of-day option chains. It is what the options market prices as the absolute move to that expiry, not a forecast of direction. Move: close before the news → close after it (before the open: prior close → report-day close; after the close: report-day close → next close), adjusted for splits and dividends, from EODHD end-of-day prices. Reports with an unannounced time are not averaged: both candidate moves are stored instead. Per-report moves, gaps, moves vs SPY and the sector, beat/miss asymmetry and implied vs actual are in Lician Pro below.

EPS actuals are checked against the SEC filing and the company’s earnings press release (8-K EX-99.1). A company that reports only GAAP EPS is graded on its SEC diluted EPS; one that reports adjusted EPS is graded on the provider’s adjusted figure when the release confirms it. A figure that matches neither is shown as unverified, with no beat or miss. Revenue actuals come from the SEC filing of the same quarter where we have it.

• Beat EPS in 1 of 4

No earnings 8-K (item 2.02) is stored for this report yet. All CNTX filings: SEC filings.

Documents link to SEC EDGAR. Lician does not publish earnings-call transcripts.